| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 528086
[patent_doc_number] => 07183390
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-27
[patent_title] => 'Humanized antibodies to gamma-interferon'
[patent_app_type] => utility
[patent_app_number] => 09/992524
[patent_app_country] => US
[patent_app_date] => 2001-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 6809
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/183/07183390.pdf
[firstpage_image] =>[orig_patent_app_number] => 09992524
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/992524 | Humanized antibodies to gamma-interferon | Nov 12, 2001 | Issued |
Array
(
[id] => 6450294
[patent_doc_number] => 20020177554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-28
[patent_title] => 'Novel peptides for use in treatment of T-cell mediated cartilage destruction in autoimmune diseases'
[patent_app_type] => new
[patent_app_number] => 09/987137
[patent_app_country] => US
[patent_app_date] => 2001-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4514
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20020177554.pdf
[firstpage_image] =>[orig_patent_app_number] => 09987137
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/987137 | Novel peptides for use in treatment of T-cell mediated cartilage destruction in autoimmune diseases | Nov 12, 2001 | Abandoned |
Array
(
[id] => 6687942
[patent_doc_number] => 20030031667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Human monoclonal antibodies to dendritic cells'
[patent_app_type] => new
[patent_app_number] => 10/035637
[patent_app_country] => US
[patent_app_date] => 2001-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 27865
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20030031667.pdf
[firstpage_image] =>[orig_patent_app_number] => 10035637
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/035637 | Molecular conjugates comprising human monoclonal antibodies to dendritic cells | Nov 6, 2001 | Issued |
Array
(
[id] => 5789570
[patent_doc_number] => 20020161210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Compositions, methods, and kits relating to resistin'
[patent_app_type] => new
[patent_app_number] => 09/986234
[patent_app_country] => US
[patent_app_date] => 2001-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 40663
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20020161210.pdf
[firstpage_image] =>[orig_patent_app_number] => 09986234
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/986234 | Compositions, methods, and kits relating to resistin | Oct 21, 2001 | Abandoned |
Array
(
[id] => 1262378
[patent_doc_number] => 06659967
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-09
[patent_title] => 'System and method for noninvasively evaluating a limb suspected of compartment syndrome'
[patent_app_type] => B1
[patent_app_number] => 10/038040
[patent_app_country] => US
[patent_app_date] => 2001-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 3797
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/659/06659967.pdf
[firstpage_image] =>[orig_patent_app_number] => 10038040
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/038040 | System and method for noninvasively evaluating a limb suspected of compartment syndrome | Oct 18, 2001 | Issued |
Array
(
[id] => 6642403
[patent_doc_number] => 20030103962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Methods and compositions for modulating the immune system of animals'
[patent_app_type] => new
[patent_app_number] => 09/973283
[patent_app_country] => US
[patent_app_date] => 2001-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9646
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20030103962.pdf
[firstpage_image] =>[orig_patent_app_number] => 09973283
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/973283 | Methods and compositions for modulating the immune system of animals | Oct 8, 2001 | Abandoned |
Array
(
[id] => 6860570
[patent_doc_number] => 20030091578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Autologous T-cell vaccines materials and methods'
[patent_app_type] => new
[patent_app_number] => 09/952532
[patent_app_country] => US
[patent_app_date] => 2001-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6947
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20030091578.pdf
[firstpage_image] =>[orig_patent_app_number] => 09952532
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/952532 | Autologous T-cell vaccines materials and methods | Sep 13, 2001 | Issued |
Array
(
[id] => 5905001
[patent_doc_number] => 20020141973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-03
[patent_title] => 'Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response'
[patent_app_type] => new
[patent_app_number] => 09/951849
[patent_app_country] => US
[patent_app_date] => 2001-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 17948
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20020141973.pdf
[firstpage_image] =>[orig_patent_app_number] => 09951849
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/951849 | Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response | Sep 9, 2001 | Abandoned |
Array
(
[id] => 6374710
[patent_doc_number] => 20020119121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-29
[patent_title] => 'Compositions and methods for inducing specific cytolytic T cell responses'
[patent_app_type] => new
[patent_app_number] => 09/948245
[patent_app_country] => US
[patent_app_date] => 2001-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 18124
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20020119121.pdf
[firstpage_image] =>[orig_patent_app_number] => 09948245
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/948245 | Compositions and methods for inducing specific cytolytic T cell responses | Sep 5, 2001 | Abandoned |
Array
(
[id] => 5950797
[patent_doc_number] => 20020006410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-17
[patent_title] => 'Method for treating inflammatory diseases using heat shock proteins'
[patent_app_type] => new
[patent_app_number] => 09/932483
[patent_app_country] => US
[patent_app_date] => 2001-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16817
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20020006410.pdf
[firstpage_image] =>[orig_patent_app_number] => 09932483
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/932483 | Method for treating inflammatory diseases using heat shock proteins | Aug 16, 2001 | Abandoned |
Array
(
[id] => 5968378
[patent_doc_number] => 20020090724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-11
[patent_title] => 'Activation of regulatory T cells by alpha-melanocyte stimulating hormone'
[patent_app_type] => new
[patent_app_number] => 09/912670
[patent_app_country] => US
[patent_app_date] => 2001-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 25929
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20020090724.pdf
[firstpage_image] =>[orig_patent_app_number] => 09912670
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/912670 | Activation of regulatory T cells by alpha-melanocyte stimulating hormone | Jul 22, 2001 | Abandoned |
Array
(
[id] => 6403044
[patent_doc_number] => 20020037290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-28
[patent_title] => 'Compositions comprising heat shock proteins or alpha(2) macroglobulin, antigenic molecules and saponins, and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 09/909778
[patent_app_country] => US
[patent_app_date] => 2001-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35818
[patent_no_of_claims] => 119
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20020037290.pdf
[firstpage_image] =>[orig_patent_app_number] => 09909778
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/909778 | Compositions comprising heat shock proteins or alpha(2) macroglobulin, antigenic molecules and saponins, and methods of use thereof | Jul 19, 2001 | Abandoned |
| 09/806689 | Novel lymphocyte population expressing intracellular mo2 | Jul 12, 2001 | Abandoned |
Array
(
[id] => 6429275
[patent_doc_number] => 20020127223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Method for reducing side effects of a drug'
[patent_app_type] => new
[patent_app_number] => 09/906322
[patent_app_country] => US
[patent_app_date] => 2001-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5525
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20020127223.pdf
[firstpage_image] =>[orig_patent_app_number] => 09906322
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/906322 | Method for reducing side effects of a drug | Jul 12, 2001 | Abandoned |
Array
(
[id] => 6567317
[patent_doc_number] => 20020165141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Methods for promoting dendritic cell proliferation or differentiation'
[patent_app_type] => new
[patent_app_number] => 09/900936
[patent_app_country] => US
[patent_app_date] => 2001-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8183
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20020165141.pdf
[firstpage_image] =>[orig_patent_app_number] => 09900936
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/900936 | Methods for promoting dendritic cell proliferation or differentiation | Jul 8, 2001 | Abandoned |
| 09/787916 | Method for inducing cellu lar immunity and cells with induced cellular immunity | Jul 8, 2001 | Abandoned |
Array
(
[id] => 6692597
[patent_doc_number] => 20030040029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-27
[patent_title] => 'Detection of tumor marker transcript and protein recognized by naive natural killer cells'
[patent_app_type] => new
[patent_app_number] => 09/896908
[patent_app_country] => US
[patent_app_date] => 2001-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 23600
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20030040029.pdf
[firstpage_image] =>[orig_patent_app_number] => 09896908
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/896908 | Detection of tumor marker transcript and protein recognized by naive natural killer cells | Jun 28, 2001 | Abandoned |
Array
(
[id] => 6496295
[patent_doc_number] => 20020025320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-28
[patent_title] => 'Sialidases as mucosal adjuvants'
[patent_app_type] => new
[patent_app_number] => 09/887530
[patent_app_country] => US
[patent_app_date] => 2001-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1983
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20020025320.pdf
[firstpage_image] =>[orig_patent_app_number] => 09887530
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/887530 | Sialidases as mucosal adjuvants | Jun 24, 2001 | Abandoned |
Array
(
[id] => 7014463
[patent_doc_number] => 20010051372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-13
[patent_title] => 'Human hematopoietic stem and progenitor cell antigen and methods for its use'
[patent_app_type] => new
[patent_app_number] => 09/881853
[patent_app_country] => US
[patent_app_date] => 2001-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14567
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20010051372.pdf
[firstpage_image] =>[orig_patent_app_number] => 09881853
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/881853 | Human hematopoietic stem and progenitor cell antigen and methods for its use | Jun 12, 2001 | Abandoned |
Array
(
[id] => 5843451
[patent_doc_number] => 20020131960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Artificial antigen presenting cells and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 09/872832
[patent_app_country] => US
[patent_app_date] => 2001-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14590
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20020131960.pdf
[firstpage_image] =>[orig_patent_app_number] => 09872832
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/872832 | Artificial antigen presenting cells and methods of use thereof | May 31, 2001 | Abandoned |